Evidence map›Paper›PMID 38764920›Full record

ReviewFrontiers in chemistry2024

Five years of advances in electrochemical analysis of protein biomarkers in lung cancer: a systematic review.

Matías Regiart, Martín A Fernández-Baldo, Bernardino Alcázar Navarrete, Concepción Morales García, Beatriz Gómez, Gonzalo R Tortella, Teresa Valero, Francisco Gabriel Ortega

Abstract readReview
In one paragraph

Review in Frontiers in chemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Matías RegiartInstituto de Química San Luis (INQUISAL), Departamento de Química, Universidad Nacional de San Luis, CONICET, San Luis, Argentina.
Martín A Fernández-BaldoInstituto de Química San Luis (INQUISAL), Departamento de Química, Universidad Nacional de San Luis, CONICET, San Luis, Argentina.
Bernardino Alcázar NavarreteIBS Granada, Institute of Biomedical Research, Granada, Spain.
Concepción Morales GarcíaIBS Granada, Institute of Biomedical Research, Granada, Spain.
Beatriz GómezIBS Granada, Institute of Biomedical Research, Granada, Spain.
Gonzalo R TortellaCentro de Excelencia en Investigación Biotecnológica Aplicada al Medio Ambiente (CIBAMA), Facultad de Ingeniería y Ciencias, Universidad de La Frontera, Temuco, Chile.
Teresa ValeroIBS Granada, Institute of Biomedical Research, Granada, Spain.
Francisco Gabriel OrtegaIBS Granada, Institute of Biomedical Research, Granada, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lung cancer is the leading cause of cancer death in both men and women. It represents a public health problem that must be addressed through the early detection of specific biomarkers and effective treatment. To address this critical issue, it is imperative to implement effective methodologies for specific biomarker detection of lung cancer in real clinical samples. Electrochemical methods, including microfluidic devices and biosensors, can obtain robust results that reduce time, cost, and assay complexity. This comprehensive review will explore specific studies, methodologies, and detection limits and contribute to the depth of the discussion, making it a valuable resource for researchers and clinicians interested in lung cancer diagnosis.

Indexed as

biomarkersbiosensorsclinical analysisdiagnosiselectrochemical methodslung cancer

Identifiers

PMID38764920
PMCPMC11099832

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.